Table 1.

Inclusion criteria for study.

All patients attending sarcoma outpatients who were:
(i) aged 18 and above,
(ii) diagnosed with sarcoma,
(iii) able to respond to an assessment written in English,
(iv) able to provide informed consent to participate in the study.

Also eligible were: patients who had received anticancer treatments (includes surgery, chemotherapy, radiotherapy and biological therapy) or were currently receiving anticancer therapy, and patients with advanced or metastatic disease.